Literature DB >> 20960291

In vivo kinetics and biodistribution of a Hantaan virus DNA vaccine after intramuscular injection in mice.

Si Wang1, Qing Nie, Lan-yan Zheng, Jun Hu, En-jie Luo.   

Abstract

To study the kinetics in vivo of a Hantaan virus DNA vaccine, we constructed a fusion DNA vaccine, pEGFP/S, by cloning the S segment of Hantavirus into the vector, pEGFP-C1, which encodes Green fluorescent protein EGFP. In this report, we provide evidence that pEGFP/S was distributed and persistently expressed for more than 60 days in several organs after inoculation. Our findings suggest that the persistent immune responses induced by a Hantaan virus DNA vaccine are likely due to the plasmid pEGFP/S deposited in vivo, which acts as a booster immunization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960291      PMCID: PMC8227945          DOI: 10.1007/s12250-010-3103-7

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  13 in total

1.  Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.

Authors:  A Abendroth; B Slobedman; M L Springer; H M Blau; A M Arvin
Journal:  Antiviral Res       Date:  1999-12-31       Impact factor: 5.970

2.  Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.

Authors:  Jay W Hooper; David M Custer; Jeffrey Smith; Victoria Wahl-Jensen
Journal:  Virology       Date:  2005-12-27       Impact factor: 3.616

3.  Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination.

Authors:  Gyu-Jin Woo; Eun-Young Chun; Keun Hee Kim; Wankee Kim
Journal:  J Microbiol       Date:  2005-12       Impact factor: 3.422

4.  Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells.

Authors:  M A Chattergoon; T M Robinson; J D Boyer; D B Weiner
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

5.  Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

Authors:  T Sparwasser; E S Koch; R M Vabulas; K Heeg; G B Lipford; J W Ellwart; H Wagner
Journal:  Eur J Immunol       Date:  1998-06       Impact factor: 5.532

6.  Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice.

Authors:  D Lew; S E Parker; T Latimer; A M Abai; A Kuwahara-Rundell; S G Doh; Z Y Yang; D Laface; S H Gromkowski; G J Nabel
Journal:  Hum Gene Ther       Date:  1995-05       Impact factor: 5.695

7.  Immunogenicity and persistence of a targeted anti-caries DNA vaccine.

Authors:  Q A Xu; F Yu; M W Fan; Z Bian; Z Chen; B Fan; R Jia; J H Guo
Journal:  J Dent Res       Date:  2006-10       Impact factor: 6.116

8.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

9.  DNA vaccination induces a long-term antibody response and protective immunity against pseudorabies virus in mice.

Authors:  T Y Ho; C Y Hsiang; C H Hsiang; T J Chang
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

10.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Authors:  E F Fynan; R G Webster; D H Fuller; J R Haynes; J C Santoro; H L Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.